To further investigate the effects of thioridazine on self-renewal, we expanded the experimental panel of breast cancer cell lines to include luminal cell lines (MCF7 and ZR751), HER2+ cell lines (BT474 and MDA-MB-361), as well as another basal-like cell line (SUM229). Here, ERBB2 is linked to breast carcinoma.